Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways
暂无分享,去创建一个
P. Schloss | S. Widder | J. Lipuma | Lisa A. Carmody | L. Kalikin | Jiangchao Zhao | Qingyang Zhang | L. Carmody
[1] J. Lipuma,et al. Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination , 2020, mSystems.
[2] Gavin M Douglas,et al. PICRUSt2 for prediction of metagenome functions , 2020, Nature Biotechnology.
[3] L. Hoffman,et al. Lung function and microbiota diversity in cystic fibrosis , 2020, Microbiome.
[4] Bradley S. Turner,et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection , 2019, Nature Microbiology.
[5] S. Widder,et al. Microbial Metabolites in Cystic Fibrosis: A Target for Future Therapy? , 2019, American journal of respiratory cell and molecular biology.
[6] Richard M Leggett,et al. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection , 2019, Nature Biotechnology.
[7] C. Goss,et al. Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. , 2019, Cell reports.
[8] Rob Knight,et al. Niche partitioning of a pathogenic microbiome driven by chemical gradients , 2018, Science Advances.
[9] L. Fajas,et al. Dietary Fiber Confers Protection against Flu by Shaping Ly6c− Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism , 2018, Immunity.
[10] M. Rogers,et al. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis , 2018, PloS one.
[11] William R. Harcombe,et al. Cross-feeding modulates antibiotic tolerance in bacterial communities , 2018, The ISME Journal.
[12] L. Hoffman,et al. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? , 2017, Current opinion in pulmonary medicine.
[13] W. T. Harris,et al. Airway microbiota across age and disease spectrum in cystic fibrosis , 2017, European Respiratory Journal.
[14] Suzanne M. Paley,et al. The MetaCyc database of metabolic pathways and enzymes , 2017, Nucleic Acids Res..
[15] J. Galeano,et al. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period , 2017, mBio.
[16] Pan-Jun Kim,et al. Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis , 2017, Nature Communications.
[17] R. Hunter,et al. Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin , 2017, Infection and Immunity.
[18] M. Surette,et al. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis , 2017, PloS one.
[19] F. Rohwer,et al. Ecological networking of cystic fibrosis lung infections , 2016, npj Biofilms and Microbiomes.
[20] É. Vivier,et al. The discontinuity theory of immunity , 2016, Science Immunology.
[21] R. Hunter,et al. Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease , 2016, bioRxiv.
[22] Casey M. Theriot,et al. Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation , 2016, mSystems.
[23] J. Lipuma,et al. Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens , 2015, Journal of Clinical Microbiology.
[24] Ahmed Abdul Azim,et al. The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. , 2015, American journal of respiratory and critical care medicine.
[25] J. Kitzman,et al. Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. , 2015, Cell host & microbe.
[26] D. Newman,et al. Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation , 2015, mBio.
[27] Z. Abdo,et al. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation , 2015, Microbiome.
[28] L. Tailford,et al. Mucin glycan foraging in the human gut microbiome , 2015, Front. Genet..
[29] L. Hoffman,et al. Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. , 2014, Annals of the American Thoracic Society.
[30] P. Schloss,et al. Dynamics and associations of microbial community types across the human body , 2014, Nature.
[31] Forest Rohwer,et al. Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.
[32] Deborah A Hogan,et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation , 2013, Microbiome.
[33] J. Petrosino,et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. , 2013, Annals of the American Thoracic Society.
[34] A. Fodor,et al. The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations , 2012, PloS one.
[35] Jonathan Friedman,et al. Inferring Correlation Networks from Genomic Survey Data , 2012, PLoS Comput. Biol..
[36] S. Dowd,et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota , 2012, Proceedings of the National Academy of Sciences.
[37] M. Sogin,et al. Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient Stability , 2012, Journal of bacteriology.
[38] L. Hoffman,et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.
[39] Susan Murray,et al. Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.
[40] J. Petrosino,et al. Impact of Enhanced Staphylococcus DNA Extraction on Microbial Community Measures in Cystic Fibrosis Sputum , 2012, PloS one.
[41] C. Quince,et al. Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics , 2012, PloS one.
[42] Patrick D. Schloss,et al. Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies , 2011, PloS one.
[43] J. M. Dow,et al. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa , 2011, The ISME Journal.
[44] J. Petrosino,et al. Effect of Sample Storage Conditions on Culture-Independent Bacterial Community Measures in Cystic Fibrosis Sputum Specimens , 2011, Journal of Clinical Microbiology.
[45] J. Parkhill,et al. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities , 2010, The ISME Journal.
[46] Eoin L. Brodie,et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.
[47] David J Van Horn,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[48] M. Konstan,et al. Characterizing aggressiveness and predicting future progression of CF lung disease. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[49] James R. Cole,et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis , 2008, Nucleic Acids Res..
[50] M. Surette,et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.
[51] N. Pace,et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.
[52] J. Lefante,et al. The precision of longitudinal lung function measurements: monitoring and interpretation , 2005, Occupational and Environmental Medicine.
[53] M. Grisham,et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum , 2000, Pediatric pulmonology.
[54] S. Lory,et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis , 2011, The ISME Journal.
[55] J. Voynow,et al. Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.